
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    ### **Step-by-Step Analysis of the Marker List for Large Intestine scRNA-seq Cluster**<br><br>---<br><br>#### **1. List the Key Functional Markers and Their Roles**  <br>The following genes are strongly associated with **neuroendocrine secretion**, **hormone processing**, and **synaptic signaling**:<br><br>- **GCG (Glucagon)**: Proglucagon-derived peptide hormone, involved in glucose metabolism.  <br>- **PCSK1 (Proprotein Convertase Subtilisin/Kexin Type 1)**: Processes prohormones (e.g., proglucagon, proinsulin).  <br>- **UCN3 (Urocortin 3)**: Neuropeptide regulating stress response and metabolism.  <br>- **PYY (Peptide YY)**: Gut hormone suppressing appetite.  <br>- **INSL5 (Insulin-like peptide 5)**: Neuropeptide involved in feeding behavior.  <br>- **CHGA (Chromogranin A)**: Granin protein, a marker for secretory vesicles in neuroendocrine cells.  <br>- **SCG2/SCG3/SCG5 (Secretogranins)**: Regulate dense-core secretory granule biogenesis.  <br>- **SLC18A1 (VMAT1)**: Vesicular monoamine transporter, critical for neurotransmitter storage.  <br>- **TPH1 (Tryptophan Hydroxylase 1)**: Rate-limiting enzyme for serotonin synthesis.  <br>- **SLC32A1 (VGAT)**: Vesicular GABA transporter, inhibitory neurotransmitter release.  <br><br>**Functional Inference**: This cluster exhibits **neuroendocrine secretory function**, with roles in **hormone processing (PCSK1, CHGA)**, **peptide hormone production (GCG, PYY, INSL5)**, and **neurotransmitter regulation (SLC18A1, SLC32A1, TPH1)**.<br><br>---<br><br>#### **2. List the Key Cell Type Markers and Their Roles**  <br>These markers are strongly associated with **enteroendocrine cells (EECs)** and **neuroendocrine differentiation**:<br><br>- **NKX2-2**: Transcription factor essential for EEC development.  <br>- **RFX6**: Critical for EEC differentiation and function.  <br>- **FEV (ETS family transcription factor)**: Regulates serotonin-producing enterochromaffin cells.  <br>- **ARX (Aristaless-related homeobox)**: Specifies a subset of EECs (e.g., GLP-1-producing L-cells).  <br>- **CHGA/CHGB (Chromogranins)**: Pan-neuroendocrine markers.  <br>- **SST (Somatostatin)**: Inhibitory hormone produced by D-cells (not in list, but related).  <br>- **SCT (Secretin)**: Hormone produced by S-cells (not dominant here).  <br><br>**Cell Type Inference**: The expression of **NKX2-2, RFX6, ARX, and hormone genes (GCG, PYY, INSL5)** strongly suggests **enteroendocrine cells (EECs)** of the gut.<br><br>---<br><br>#### **3. Cross-reference Known Databases**  <br>- **Human Cell Atlas (HCA)**: EECs in the colon express **GCG, PYY, CHGA, NKX2-2, RFX6**.  <br>- **Gut Cell Atlas (GCA)**: L-cells (GLP-1/PYY-producing) and enterochromaffin (EC) cells (serotonin-producing) share **TPH1, CHGA, SCG genes**.  <br>- **SingleR & CellMarker**:  <br>  - **L-cells**: GCG, PYY, PCSK1, RFX6.  <br>  - **EC-cells**: TPH1, CHGA, FEV.  <br>  - **I-cells (CCK-producing)**: Not dominant here.  <br><br>**Database Consensus**: The markers align best with **L-cells (GLP-1/PYY-producing)** and **EC-cells (serotonin-producing)**.<br><br>---<br><br>#### **4. Determine the Most Probable General Cell Type**  <br>The **overwhelming presence of EEC markers (GCG, PYY, CHGA, NKX2-2, RFX6, ARX, TPH1)** confirms this cluster as:  <br>**General Cell Type: Enteroendocrine Cells (EECs) of the Large Intestine**.<br><br>---<br><br>#### **5. Identify the Top 3 Most Probable Sub Cell Types**  <br>Ranked by marker support:  <br><br>1. **L-cells (GLP-1/PYY-producing)**  <br>   - **Key markers**: GCG, PYY, PCSK1, RFX6, ARX.  <br>   - **Rationale**: Dominant expression of **GCG (glucagon) and PYY**, which are hallmark L-cell hormones.  <br><br>2. **Enterochromaffin (EC) cells (serotonin-producing)**  <br>   - **Key markers**: TPH1, CHGA, FEV, SLC18A1.  <br>   - **Rationale**: **TPH1 (serotonin synthesis enzyme)** and **FEV (EC-cell regulator)** suggest a serotonin-secreting subset.  <br><br>3. **K-cells (GIP-producing) or I-cells (CCK-producing)**  <br>   - **Key markers**: Weak support (no GIP or CCK in list).  <br>   - **Rationale**: Less likely due to absence of GIP or CCK.  <br><br>**Most Likely Subtype**: **L-cells (GLP-1/PYY-producing)** due to dominant **GCG/PYY** expression.  <br><br>---<br><br>#### **6. Concise Summary of Analysis**  <br>- **Functional Markers**: Neuroendocrine secretion (GCG, PYY, INSL5, CHGA, PCSK1, TPH1).  <br>- **Cell Type Markers**: EEC-specific (NKX2-2, RFX6, ARX).  <br>- **Database Alignment**: Matches L-cells (GLP-1/PYY) and EC-cells (serotonin).  <br>- **General Cell Type**: **Enteroendocrine Cells (EECs)**.  <br>- **Top Subtype**: **L-cells (GLP-1/PYY-producing)**.  <br><br>**FINAL ANNOTATION COMPLETED**:  <br>**Cell Type**: **Enteroendocrine L-cells (GLP-1/PYY-producing) of the Large Intestine**.  <br><br>(If additional validation suggests mixed EC-cell features, the annotation could be refined to **"EEC subset with L-cell/EC-cell hybrid features."**)
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    ### **Validation Report**  <br><br>#### **1. Marker Consistency Check**  <br>‚úÖ **All key functional and cell type markers are present in the provided list**:  <br>- **L-cell markers (GCG, PYY, PCSK1, RFX6, ARX)**  <br>- **EC-cell markers (TPH1, CHGA, FEV, SLC18A1)**  <br>- **Pan-EEC markers (NKX2-2, CHGA, SCG genes, INSM1)**  <br><br>‚úÖ **No major missing markers**: The annotation correctly highlights **GCG, PYY, TPH1, CHGA, NKX2-2, RFX6, ARX**, which are all in the marker list.  <br><br>#### **2. Functional and Cell Type Alignment**  <br>‚úÖ **Neuroendocrine function is well-supported**:  <br>- **Hormone processing (PCSK1, CHGA, SCG genes)**  <br>- **Peptide secretion (GCG, PYY, INSL5, UCN3)**  <br>- **Neurotransmitter regulation (TPH1, SLC18A1, SLC32A1)**  <br><br>‚úÖ **EEC identity is strongly justified**:  <br>- **NKX2-2, RFX6, ARX** are key EEC transcription factors.  <br>- **GCG/PYY dominance** aligns with **L-cell identity**.  <br>- **TPH1/FEV** suggests **EC-cell contribution**, but **L-cell markers are more dominant**.  <br><br>#### **3. Mixed Cell Type Consideration**  <br>‚ö† **Potential minor EC-cell contribution**:  <br>- **TPH1 (serotonin synthesis)** and **FEV (EC-cell regulator)** are present but **not dominant** compared to **GCG/PYY**.  <br>- **Not strong enough to reject L-cell annotation**, but could be noted as **"L-cell-dominant with possible EC-cell features."**  <br><br>#### **4. Database Cross-Validation**  <br>‚úÖ **Matches Human/Gut Cell Atlas references**:  <br>- **L-cells**: GCG, PYY, PCSK1, RFX6 (‚úî)  <br>- **EC-cells**: TPH1, CHGA, FEV (‚úî, but secondary)  <br><br>#### **Final Decision**  <br>‚úÖ **VALIDATION PASSED**  <br>- **Primary annotation ("Enteroendocrine L-cells") is correct** based on marker dominance.  <br>- **Minor EC-cell signal does not invalidate the call**, but could be optionally noted in the annotation for precision (e.g., "L-cells with EC-like features").  <br><br>**Suggested Refinement (Optional)**:  <br>If desired, the annotation could be updated to:  <br>**"Enteroendocrine L-cells (GLP-1/PYY-producing) with minor EC-cell features (TPH1+)"**  <br>to reflect the subtle mixed signature.  <br><br>---  <br>**Validation result: VALIDATION PASSED**
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Enteroendocrine Cells (EECs) of the Large Intestine</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>L-cells (GLP-1/PYY-producing)</li><li>Enterochromaffin (EC) cells (serotonin-producing)</li><li>K-cells (GIP-producing) or I-cells (CCK-producing)</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li>EEC subset with L-cell/EC-cell hybrid features</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">95</div>
                        <div class="scoring-content">
                            The annotation results for this single-cell cluster from the human large intestine are well-justified and scientifically accurate. The analysis correctly identifies the cluster as **Enteroendocrine Cells (EECs)**, with a strong emphasis on **L-cells (GLP-1/PYY-producing)** due to the dominance of key markers like **GCG, PYY, PCSK1, RFX6, and ARX**. The inclusion of **TPH1, FEV, and SLC18A1** also acknowledges a minor contribution from **Enterochromaffin (EC) cells**, which adds nuance to the annotation without detracting from the primary L-cell identity.  <br><br>### **Strengths**:  <br>1. **Correctness of Annotations**:  <br>   - The primary annotation as **EECs** is supported by pan-neuroendocrine markers (**CHGA, SCG genes, NKX2-2, RFX6**).  <br>   - The sub-annotation as **L-cells** is justified by the high expression of **GCG and PYY**, which are hallmark hormones for this subtype.  <br>   - The consideration of **EC-cell features (TPH1, FEV)** demonstrates thoroughness in capturing mixed signals.  <br><br>2. **Balanced Marker Usage**:  <br>   - The analysis does not over-rely on a single marker but instead integrates multiple lines of evidence (hormones, processing enzymes, transcription factors).  <br>   - Key markers are ranked appropriately (e.g., **GCG and PYY** are prioritized over **TPH1**, reflecting their dominance in L-cells).  <br><br>3. **Comprehensive View**:  <br>   - The annotation captures both the **general EEC identity** and **specific subtypes (L-cells, EC-cells)**.  <br>   - The optional refinement ("L-cells with EC-like features") shows awareness of subtle heterogeneity.  <br><br>4. **Database Alignment**:  <br>   - Cross-referencing with **Human Cell Atlas (HCA)** and **Gut Cell Atlas (GCA)** strengthens the validity of the annotation.  <br><br>### **Weaknesses**:  <br>1. **Minor Overlap with Other EEC Subtypes**:  <br>   - The mention of **K-cells (GIP-producing) or I-cells (CCK-producing)** is weakly supported, as neither **GIP nor CCK** are in the marker list. This could be omitted for clarity.  <br><br>2. **Optional Refinement Could Be Default**:  <br>   - The **"L-cells with EC-like features"** annotation is more precise and could be the primary call instead of an optional refinement.  <br><br>### **Final Assessment**:  <br>The annotation is **highly accurate**, with only minor room for improvement in refining the subtype call. The analysis successfully balances marker evidence, captures the general EEC identity, and acknowledges subtle heterogeneity.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    